Literature DB >> 12461108

Cancer screening.

A Barratt1, P Mannes, L Irwig, L Trevena, J Craig, L Rychetnik.   

Abstract

"Screening is the systematic application of a test or inquiry, to identify individuals at sufficient risk of a specific disorder to benefit from further investigation or direct preventive action, among persons who have not sought medical attention on account of symptoms of that disorder."

Entities:  

Mesh：

Year:  2002        PMID： 12461108      PMCID： PMC1756972          DOI： 10.1136/jech.56.12.899

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


  20 in total

1.  The number needed to screen--an adaptation of the number needed to treat.

Authors:  M R Law
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

2.  Information about screening - is it to achieve high uptake or to ensure informed choice?

Authors:  A E Raffle
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

3.  Guidance on terminology.

Authors:  N J Wald
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

4.  Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.

Authors:  A Barratt; L Irwig; P Glasziou; R G Cumming; A Raffle; N Hicks; J A Gray; G H Guyatt
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

5.  Cochrane review on screening for breast cancer with mammography.

Authors:  O Olsen; P C Gøtzsche
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

6.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

Review 7.  False-negative results in screening programmes: systematic review of impact and implications.

Authors:  M P Petticrew; A J Sowden; D Lister-Sharp; K Wright
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

8.  A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.

Authors:  Robert E Schoen; Joel L Weissfeld; Jeanette M Trauth; Bruce S Ling; Mutlu Hayran
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

9.  Screening and the number needed to treat.

Authors:  A Richardson
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

10.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15
View more
  7 in total

1.  No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma.

Authors:  Yutaka Midorikawa; Tadatoshi Takayama; Satoshi Nara; Takuya Hashimoto; Kiyohiko Omichi; Kiyoko Ebisawa; Tokio Higaki; Shingo Tsuji; Hirohiko Sakamoto; Kazuaki Shimada; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

Review 2.  Systematic screening for the detection of atrial fibrillation.

Authors:  Patrick S Moran; Conor Teljeur; Mairin Ryan; Susan M Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-06-03

3.  Use of text-message reminders to improve participation in a population-based breast cancer screening program.

Authors:  C Vidal; M Garcia; L Benito; N Milà; G Binefa; V Moreno
Journal:  J Med Syst       Date:  2014-07-30       Impact factor: 4.460

4.  Mammography rates for breast cancer screening: a comparison of First Nations women and all other women living in Manitoba, Canada, 1999-2008.

Authors:  Alain A Demers; Kathleen M Decker; Erich V Kliewer; Grace Musto; Emma Shu; Natalie Biswanger; Katherine Fradette; Brenda Elias; Jane Griffith; Donna Turner
Journal:  Prev Chronic Dis       Date:  2015-05-28       Impact factor: 2.830

5.  Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania.

Authors:  Ausvydas Patasius; Agne Krilaviciute; Giedre Smailyte
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

6.  Uptake in cancer screening programmes: a priority in cancer control.

Authors:  D P Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

7.  Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data.

Authors:  Lena Steinkasserer; Delmarko Irmgard; Tatjana Weiss; Walter Dirschlmayer; Michael Mossig; Alain G Zeimet; Christian Marth
Journal:  Arch Gynecol Obstet       Date:  2021-06-14       Impact factor: 2.344
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.